Skip to content

{ Tag Archives } Oral

Genta Initiates Phase 2 Study Of Tesetaxel, The Leading Clinical-Stage Oral Taxane, In Patients With Advanced Melanoma

Genta Incorporated (OTCBB: GETA) announced that the Company has initiated treatment of the first subject in a new Phase 2 trial of tesetaxel in advanced melanoma. Tesetaxel is the Company’s newest clinical-stage small molecule. As a late Phase 2 oncology product, tesetaxel is the leading oral taxane currently in clinical development…

Bookmark and Share Also tagged , , , , , ,
2010 02 10 Skin Care News Comments Off

Novexel Starts Phase II Clinical Trial With NXL103 In Adults With Acute Bacterial Skin And Skin Structure Infections (ABSSSI)

Novexel, a speciality pharmaceutical company focused on the discovery and development of novel antibiotics designed to overcome the significant global problem of microbial resistance, announces that its most advanced oral antibacterial NXL103 (flopristin/linopristin), has started a Phase II clinical trial in adults with acute bacterial skin and skin structure infections (ABSSSI).

Bookmark and Share Also tagged , , , , , , , , , , , ,
2009 11 07 Skin Care News Comments Off

Research Yields Potential Target For Cancer, Wound Healing And Fibrosis

Research conducted by Allison Berrier, PhD, Assistant Professor of Oral and Craniofacial Biology at the LSU Health Sciences Center New Orleans School of Dentistry, and colleagues, provides insights that may help scientists design novel approaches to control wound healing and fight diseases such as cancer and fibrosis.

Bookmark and Share Also tagged , , , , , , , , , , , , , , , , , ,
2009 03 20 Skin Care News Comments Off